inflarx.de (IFRX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
This chart of current quotes for InflaRx N.V. (IFRX), a company specializing in immunotherapy, shows an EV/EBITDA of 0.00. A high price per unit of the drug combined with limited government orders is constraining profits. The business relies on external contractors for synthesis and testing, creating a risk of vendor dependency. Global political fragmentation further blocks the export of innovations and the supply of critical components.
inflarx.de - analytical breakdowns and key metrics (IFRX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
IFRX - Profit After Tax|Expected Profit InflaRx N.V.|IFRX - Price to Earnings Ratio|Forward P/E Multiple InflaRx|IFRX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization IFRX|IFRX - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months InflaRx|IFRX - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months inflarx.de|IFRX - Earnings per share increase in current year|Net earnings per share growth forecast for next year InflaRx N.V.
Initial company analysis:InflaRx GmbH IFRX
To isolate fundamental stability from market noise, the ratio of enterprise value to earnings before interest and taxes is calculated, allowing for an assessment of real asset value relative to operational efficiency. Analyzing the EV/EBITDA multiple of InflaRx N.V. (IFRX) helps determine the degree of stock overheating against the backdrop of current viral infection drug sales and the expected commercialization of innovative anti-inflammatory agents.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ABCL|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Precigen Inc - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NKTR (Nektar Corp)|EV/EBITDA Multiple UPB (Upstream Bio Inc)|EV/EBITDA Multiple zenasbio.com ZBIO|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation GOSS (Gossamer Bio Inc)|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation SEPN|Enterprise Value to EBITDA Ratio PVLA|SVRA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Rigel Pharmaceuticals, Inc. (RIGL)|AnaptysBio Inc - Enterprise Value to Operating Income Before Depreciation|Astria Pharma - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio enGene Corp (ENGN)|RAPT: Enterprise Value to EBITDA Ratio|JBIO: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACRS (Aclaris Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|KYTX - Total Company Value to Operating Income Before Depreciation Ratio|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Cabaletta Bio Inc (CABA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple VTYX|THTX: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|Business Value to Operating Income Before Depreciation ELDN|AGEN: Enterprise Value to EBITDA Ratio|CLYM (Climb Bio, Inc) - Enterprise Value to Operating Income Before Depreciation|Zura Bio (ZURA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ATYR (atyrpharma.com)|ADAG (Adagene Inc) - EV/EBITDA Multiple|IMA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple STTK|EV/EBITDA Multiple equilliumbio.com (EQ)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|Business Value to Operating Income Before Depreciation IMUX|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|X4 Pharmaceuticals Inc. (XFOR) - Enterprise Value to EBITDA Ratio|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio INMB|BRNS: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KZR|Total Company Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|iBio Inc (IBIO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to Operating Income Before Depreciation XTLB (XTL Bio)|EV/EBITDA Multiple BOLT|HCWB - Company Value to EBITDA|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI (GRI Bio Corporation) - Enterprise Value to Operating Income Before Depreciation|XRTX: EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio HIND (reshapelifesciences.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INDP|EV/EBITDA Multiple SCNI|EV/EBITDA Multiple calcimedica.com (CALI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|Business Value to Operating Income Before Depreciation ALLK|HOOK: Enterprise Value to EBITDA Ratio|IGMS (IGM Biosciences, Inc.) - Enterprise Value to Operating Income Before Depreciation|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Enterprise Value to Operating Income Before Depreciation THRD (thirdharmonicbio.com)
